CSL (CSJ.F) Stock Highlights

166.44 | +0.6%

2024-12-21 00:12:37

CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the worlds second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include non-plasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.

Statistics

Range Today

164.72 166.44

Volume Today 17

Range 1 Year

160.66 192

Volume 1 Year 3.57K

Range 3 Year

136.05 205.95

Volume 3 Year 12.79K

Range 10 Year

54.725 212.9

Volume 10 Year 194.38K

Highlights

Market Capitalization 84.41B (large)

Floating Shares 482.99M

Current Price 166.44

Price To Earnings 31.74

Price To Revenue 6.25

Price To Book 4.63

Earnings Per Share 5.19

Dividend Yield 1.48%

Dividend Per Share 2.44

Payout Ratio 45.18%

Performance

Latest +0.6%

1 Month -0.08%

3 Months -6.32%

6 Months -7.23%

1 Year -3.65%

3 Years -4.05%

5 Years -4.84%

10 Years +186.29%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.